From April 11 to 12, 2025, the 3rd Sino-French International Symposium on Translational Medicine and Precision Diagnosis & Treatment was held in Shanghai. Co-hosted by the Chinese Academy of Engineering (CAE), the French National Academy of Medicine, the Chinese Academy of Medical Sciences (CAMS) and Shanghai Jiao Tong University, the event was jointly organized by Shanghai Jiao Tong University School of Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Sino-French Joint School of Medicine of Shanghai Jiao Tong University School of Medicine, and Shanghai Guangci Translational Medicine Research and Development Foundation. Dozens of academy members and experts from China and France conducted in-depth discussions on the increasingly complex global health challenges and evolving disease spectra, with a focused emphasis on the prevention and control of non-communicable chronic diseases (NCDs), a topic that has garnered growing attention in recent years.

    Chen Zhu, Co-Chair of the Symposium and member of the Chinese Academy of Sciences (CAS),  the 13 delegates led by Jean-Noël Fiessinger, Co-Chair of the Symposium and President of the French National Academy of Medicine, Wang Chen, Vice President of CAE and President of CAMS, as well as CAE Members Fan Xianqun and Chen Saijuan attended the event. Wang Chen delivered the opening address and presented a keynote speech titled "Great Health: Scope and Definition".

    Against the backdrop of increasingly intricate global health challenges and shifting disease profiles, translational medicine and precision diagnosis & treatment have emerged as pivotal drivers of modern medical advancement, offering innovative solutions for healthcare in the 21st century. The symposium yielded multiple consensuses and cooperation intentions, which will effectively advance practical collaboration between the two countries in medical education, scientific research and innovation, and clinical practice.